Group 1 - The core viewpoint highlights the significant growth and performance of the innovative pharmaceutical ETF (560900), which has seen a 1.64% increase and is experiencing active trading with a turnover of 12.59% and a transaction volume of 4.4435 million yuan [1] - The CSI Innovative Pharmaceutical Industry Index (931152) has also shown strong performance, rising by 1.83%, with notable increases in constituent stocks such as Rongchang Bio (688331) up 10.28%, Zai Lab (688266) up 6.28%, and Yifan Pharmaceutical (002019) up 5.77% [1] - As of June 30, the innovative pharmaceutical ETF (560900) has seen a significant increase in shares by 500,000, ranking first among comparable funds [1] Group 2 - According to Guojin Securities, the global competitiveness of innovative drugs is becoming more prominent, with accelerated external licensing and a trend towards profitability in the industry [1] - The number and quality of new drug approvals in China have continued to improve since the beginning of 2025, with an increasing pace of commercialization for innovative drugs and the introduction of internationally leading new drugs into China [1] - The innovative pharmaceutical sector, which has experienced several years of stagnation, is now considered to be in a value trough [1] Group 3 - The rise of AI is driving a new wave of technological advancements, prompting Morgan Asset Management to integrate its "Global Vision Investment Technology" product line to assist investors in strategically positioning themselves in quality tech companies [1] - Morgan's actively managed funds focus on emerging industry trends, including the Morgan Emerging Power Fund and the Morgan Smart Connectivity Fund, which targets opportunities in artificial intelligence [2] - The passive investment options include the Morgan Hang Seng Technology ETF and the Morgan CSI Innovative Pharmaceutical Industry ETF, providing easy access to Chinese innovative pharmaceutical companies [2]

Group 1 - The core viewpoint of the news highlights the strong performance of the Science and Technology Innovation Information Technology ETF Morgan (588770), which has seen a 2.02% increase, marking its third consecutive rise, with a trading volume of 5.2522 million yuan [1] - The underlying index, the Shanghai Stock Exchange Science and Technology Innovation Board New Generation Information Technology Index (000682), has also shown robust growth, increasing by 2.16% [1] - Notable individual stocks within the index include Wealth Trend (688318) rising by 17.83%, Shengke Communication (688702) up by 8.21%, and Naxin Micro (688052) increasing by 7.18% [1] Group 2 - Over the past week, the Science and Technology Innovation Information Technology ETF Morgan (588770) has accumulated a 2.29% increase, ranking in the top third among comparable funds [2] - The Lujiazui Forum has introduced the "Science and Technology Innovation Board 1+6" reform package, which is expected to enhance the capital market reform efforts [2] - There is an anticipated increase in support for private science and technology enterprises in terms of financing and mergers and acquisitions, which is expected to catalyze leading technology companies with financing or investment needs [2] Group 3 - The Science and Technology Innovation Information Technology Index comprises 50 large-cap companies from sectors such as next-generation information networks, electronic core, emerging software, and new information technology services [2] - The rise of AI is driving a new wave of technological advancements, prompting Morgan Asset Management to integrate its "Global Vision Investment Technology" product line to help investors capitalize on quality technology companies globally [2] - Various actively managed funds focus on emerging industry trends, AI opportunities, and sectors like new energy vehicles and humanoid robots, while passive investment options include ETFs targeting technology assets in Hong Kong and innovative pharmaceutical companies in China [3]

2025年6月16日，恒生科技HKETF(513890)午后震荡涨超1%，截至13:33，该基金盘中换手14.47%，成 交6339.10万元，市场交投活跃。跟踪指数恒生科技指数(HSTECH)上涨0.57%，成分股金山软件(03888) 上涨12.50%，商汤-W(00020)上涨4.96%，小米集团-W(01810)上涨3.85%，哔哩哔哩-W(09626)上涨 3.13%，快手-W(01024)上涨2.24%。 截至6月13日，恒生科技HKETF(513890)最新规模达4.37亿元，创成立以来新高。资金流入方面，恒生 科技HKETF最新资金净流入1808.35万元，近5个交易日合计"吸金"1698.08万元。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 华泰证券指出，港股近两月演绎反弹行情，目前点位接近2025年一季度高点。往前看，利率、风险溢价 和盈利三因素视角下市场或缺乏短期大幅上行的基础，叠加三季度全球经济和地缘环境不确定性仍然较 高，华泰证券认为指数短期内可能重回震荡。在海内外投资者对中国资产关注上升、港股扩容带来趋势 性增配环境下，市场大幅下行风险相对可控，但板块 ...

2025年5月28日，恒生科技HKETF(513890)盘中一度涨近1%，截至10:11，该基金盘中换手4.59%，成交 1911.43万元。跟踪指数恒生科技指数(HSTECH)上涨0.09%，成分股快手-W(01024)上涨5.03%，小米集 团-W(01810)上涨2.62%，网易-S(09999)上涨2.39%，腾讯音乐-SW(01698)上涨1.79%，美的集团(00300) 上涨1.16%。 主动管理方面，摩根新兴动力基金（A类：377240 C类：014642）从长期视角争取把握新兴产业趋势； 摩根智慧互联基金（A类：001313 C类：016919）聚焦人工智能相关领域机会；摩根动力精选基金（A 类：006250 C类：013137）关注新能源车产业链、人形机器人等领域；摩根慧选成长基金（A类： 008314 C类：008315），布局A+H优质成长企业；摩根太平洋科技基金（PRC人民币对冲（累计） 968061，PRC人民币（累计）968962，PRC美元份额（累计）968063）精选太平洋地区优质科技企业。 被动投资方面，摩根恒生科技ETF（QDII）（证券代码：513890 ，联接A类：0 ...